[Postpartal lactation inhibition by 2-Br-alpha-ergocryptine: II. A comparative study with 2-Br-alpha-ergocryptine and methallenoestrol (author's transl)].
D001966:Bromine / Q000008:administration & dosage / Q000494:pharmacology; D004876:Ergot Alkaloids / Q000494:pharmacology*; D004967:Estrogens / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007774:Lactation / Q000187:drug effects*; D008598:Menstruation; D011247:Pregnancy; D013997:Time Factors
D004876:Ergot Alkaloids; D004967:Estrogens; D001966:Bromine
Postpartale Laktationshemmung durch 2-Br-Alpha-Ergokryptin: II. Eine Vergleichsuntersuchung mit 2-Br-Alpha-Ergokryptin und Methallenöstrol